Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Benign Hematologic Diseases

3 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Other

VICCNCPED10104

09/17/2004

Severe Chronic Neutropenia International Registry

Treatment

VICCNCBMT12108

05/08/2013

A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies

Treatment

VICCNCPED10100

02/22/2010

An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects with Immune (Idiopathic) Thrombocytopenia Purpura (ITP)